Novel uses of combined 5-HT1A agonists and serotonin reuptake inhibitors

Details for Australian Patent Application No. 2002215027 (hide)

Owner Merck Patent GmbH

Inventors Bartoszyk, Gerd

Agent Davies Collison Cave

Pub. Number AU-B-2002215027

PCT Pub. Number WO02/40024

Priority 00124815 14.11.00 EP

Filing date 16 October 2001

Wipo publication date 27 May 2002

Acceptance publication date 5 October 2006

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

5 October 2006 Application Accepted

  Published as AU-B-2002215027

1 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002215028-Method of operating a computer system to perform a discrete substructural analysis

2002215026